Evidence map›Paper›PMID 42029868›Full record

ArticleCVIR endovascular2026

Three-year outcomes of the TCD-17187 (Kanshas) drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery.

Shu-Ichi Seki, Yoshimitsu Soga, Osamu Iida, Daizo Kawasaki, Hitoshi Anzai, Hiroshi Ando, Tatsuya Nakama, Norihiko Shinozaki, Amane Kozuki, Masaharu Ishihara and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CVIR endovascular, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Shu-Ichi SekiDepartment of Medicine and Cardiology, Chikamori Hospital, Kochi, Japan. serendipityjp2004@yahoo.co.jp.ORCID http://orcid.org/0009-0000-1498-4408
Yoshimitsu SogaDepartment of Cardiology, Kokura Memorial Hospital, Fukuoka, Japan.
Osamu IidaDivision of Cardiology, Cardiovascular Center, Osaka Police Hospital, Osaka, Japan.
Daizo KawasakiDepartment of Cardiology, Morinomiya Hospital, Osaka, Japan.
Hitoshi AnzaiDepartment of Cardiology, SUBARU Health Insurance Ota Memorial Hospital, Gunma, Japan.
Hiroshi AndoHeart Center, Kasukabe Chuo General Hospital, Saitama, Japan.
Tatsuya NakamaDepartment of Cardiology, Tokyo Bay Medical Center, Chiba, Japan.
Norihiko ShinozakiDepartment of Cardiology, Tokai University Hospital, Kanagawa, Japan.
Amane KozukiDivision of Cardiology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
Masaharu IshiharaDepartment of Cardiovascular and Renal Medicine, School of Medicine, Hyogo Medical University, Hyogo, Japan.
Kazushi UrasawaDepartment of Cardiology, Caress Memorial Hospital, Hokkaido, Japan.
Fumiyuki HayashiDivision of Minimally Invasive Treatment in Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
Hiroaki TsujitaDivision of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Kazuki TobitaCardiology and Catheterization Laboratories, Shonan Kamakura General Hospital, Kanagawa, Japan.
Kenji OgataDepartment of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Japan.
Kazunori HorieDepartment of Cardiovascular Medicine, Sendai Kousei Hospital, Miyagi, Japan.
Naoki HayakawaDepartment of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan.
Shinsuke MoriDepartment of Cardiology, Saiseikai Yokohama City Eastern Hospital, Kanagawa, Japan.
Masahiko FujiharaDepartment of Cardiology, Nozaki Tokushukai Hospital, Osaka, Japan.
Takao OhkiDivision of Vascular Surgery, Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.
Kenichiro YubaDepartment of Cardiology, Tokushima Red Cross Hospital, Tokushima, Japan.
Toshiaki ManoCardiovascular Center, Kansai Rosai Hospital, Hyogo, Japan.
Masato NakamuraDivision of Minimally Invasive Treatment in Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
T. C. D.-17187 Japan Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to evaluate the safety and effectiveness of the Kanshas drug-coated balloon (DCB) with paclitaxel for the treatment of atherosclerotic lesions in the superficial femoral artery (SFA) and/or proximal popliteal artery (PA) over a 3-year period.

resultsA prospective, multicenter, single-arm trial enrolled 121 patients with symptomatic lower extremity artery disease (LEAD). At 3 years, the primary patency rate was 63.4%, and freedom from clinically driven target lesion revascularization (CD-TLR) was 83.2%. Sustained improvements were observed in Rutherford classification, ankle brachial index (ABI), and walking impairment questionnaire (WIQ) scores. No device- or procedure-related deaths or major amputations occurred.

conclusionsThe Kanshas DCB showed favorable safety and effectiveness for treating atherosclerotic lesions in the SFA and/or proximal PA over 3 years. TRAIL REGISTRATION: Registration ID: UMIN000034122. Registration Date: September 13, 2018. Registration site URL: https://center6.umin.ac.jp/cgi-openbin/ctr/ctr.cgi?function=brows&action=brows&recptno=R000038612&type=summary&language=J .

Indexed as

Clinical outcomesDrug-coated balloonPeripheral artery diseasePopliteal arteryPrimary patencySuperficial femoral artery

Identifiers

PMID42029868
PMCPMC13109471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.